Gene · 79813
Papers2,587
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,587
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomics and Epigenomics in the Molecular Biology of Melanoma-A Prerequisite for Biomarkers Studies. | Int J Mol Sci | 2022 | 36614156 | PubTator, text mining | PubMed |
| Epimutations and Their Effect on Chromatin Organization: Exciting Avenues for Cancer Treatment. | Cancers (Basel) | 2022 | 36612210 | PubTator, text mining | PubMed |
| Can glucagon-like peptide-1 receptor agonists cause acute kidney injury? An analytical study based on post-marketing approval pharmacovigilance data. | Front Endocrinol (Lausanne) | 2022 | 36583004 | PubTator, text mining | PubMed |
| Targets of histone H3 lysine 9 methyltransferases. | Front Cell Dev Biol | 2022 | 36568972 | PubTator, text mining | PubMed |
| Elevated circulating GPHB5 levels in women with insulin resistance and polycystic ovary syndrome: A cross-sectional study and multiple intervention studies. | Front Endocrinol (Lausanne) | 2022 | 36568071 | PubTator, text mining | PubMed |
| [PRION+] States Are Associated with Specific Histone H3 Post-Translational Modification Changes. | Pathogens | 2022 | 36558770 | PubTator, text mining | PubMed |
| 53BP1: Keeping It under Control, Even at a Distance from DNA Damage. | Genes (Basel) | 2022 | 36553657 | PubTator, text mining | PubMed |
| A TSHZ3 Frame-Shift Variant Causes Neurodevelopmental and Renal Disorder Consistent with Previously Described Proximal Chromosome 19q13.11 Deletion Syndrome. | Genes (Basel) | 2022 | 36553458 | PubTator, text mining | PubMed |
| A Review of the Recent Advances in Alzheimer's Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics. | Diagnostics (Basel) | 2022 | 36552984 | PubTator, text mining | PubMed |
| Large-Scale Functional Assessment of Genes Involved in Rare Diseases with Intellectual Disabilities Unravels Unique Developmental and Behaviour Profiles in Mouse Models. | Biomedicines | 2022 | 36551904 | PubTator, text mining | PubMed |
| Statin Use and Severe Acute Liver Injury Among Patients with Elevated Alanine Aminotransferase. | Clin Epidemiol | 2022 | 36540900 | PubTator, text mining | PubMed |
| The catcher in the gut: Tirzepatide, a dual incretin analog for the treatment of type 2 diabetes mellitus and obesity. | Metabol Open | 2022 | 36530219 | PubTator, text mining | PubMed |
| Novel Antidiabetic Medications in Polycystic Ovary Syndrome. | Discoveries (Craiova) | 2022 | 36518222 | PubTator, text mining | PubMed |
| Effects of Ingesting Both Catechins and Chlorogenic Acids on Glucose, Incretin, and Insulin Sensitivity in Healthy Men: A Randomized, Double-Blinded, Placebo-Controlled Crossover Trial. | Nutrients | 2022 | 36501092 | PubTator, text mining | PubMed |
| Screening and Molecular Mechanisms of Novel ACE-Inhibitory Peptides from Gracilariopsis lemaneiformis. | Int J Mol Sci | 2022 | 36499176 | PubTator, text mining | PubMed |
| Epigenetic Regulation in Chromium-, Nickel- and Cadmium-Induced Carcinogenesis. | Cancers (Basel) | 2022 | 36497250 | PubTator, text mining | PubMed |
| PALI1 promotes tumor growth through competitive recruitment of PRC2 to G9A-target chromatin for dual epigenetic silencing. | Mol Cell | 2022 | 36476474 | PubTator, text mining | PubMed |
| Potential Roles of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) in Nondiabetic Populations. | Cardiovasc Ther | 2022 | 36474714 | PubTator, text mining | PubMed |
| Analysis of genome-wide knockout mouse database identifies candidate ciliopathy genes. | Sci Rep | 2022 | 36456625 | PubTator, text mining | PubMed |
| Whole-exome sequencing study identifies rare variants and genes associated with intraocular pressure and glaucoma. | Nat Commun | 2022 | 36450729 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79813/papers?page=22